Please select the option that best describes you:

Given RADICALS-HD, are you completing 24 mo vs 6 mo of ADT with XRT following RP?  

RADICALS-HD trial (ESMO 2022) demonstrated metastasis free survival benefit with 24 months compared to 6 months of ADT.



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Tennessee Oncology
I too await the full manuscript, which I hope will...
Radiation Oncologist at Kansas City VA Medical Center
I look at several prognostic factors, most importa...
Sign in or Register to read more